nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—CYP2D6—Bicalutamide—prostate cancer	0.105	0.505	CbGbCtD
Hydroxyurea—CYP2D6—Abiraterone—prostate cancer	0.0867	0.418	CbGbCtD
Hydroxyurea—CYP2D6—Doxorubicin—prostate cancer	0.016	0.0773	CbGbCtD
Hydroxyurea—RRM2—prostate gland—prostate cancer	0.0102	0.131	CbGeAlD
Hydroxyurea—RRM1—prostate gland—prostate cancer	0.00849	0.109	CbGeAlD
Hydroxyurea—RRM1—Fulvestrant—Estradiol—prostate cancer	0.00741	1	CbGdCrCtD
Hydroxyurea—RRM1—seminal vesicle—prostate cancer	0.00718	0.092	CbGeAlD
Hydroxyurea—CYP2D6—urine—prostate cancer	0.00703	0.09	CbGeAlD
Hydroxyurea—RRM2—renal system—prostate cancer	0.00697	0.0892	CbGeAlD
Hydroxyurea—RRM1—renal system—prostate cancer	0.00579	0.0741	CbGeAlD
Hydroxyurea—RRM1—urethra—prostate cancer	0.00569	0.0728	CbGeAlD
Hydroxyurea—RRM2—bone marrow—prostate cancer	0.00527	0.0675	CbGeAlD
Hydroxyurea—RRM2—testis—prostate cancer	0.0045	0.0577	CbGeAlD
Hydroxyurea—RRM1—bone marrow—prostate cancer	0.00438	0.0561	CbGeAlD
Hydroxyurea—RRM1—testis—prostate cancer	0.00374	0.0479	CbGeAlD
Hydroxyurea—RRM2—lymph node—prostate cancer	0.00326	0.0418	CbGeAlD
Hydroxyurea—RRM1—lymph node—prostate cancer	0.00271	0.0347	CbGeAlD
Hydroxyurea—CYP2D6—renal system—prostate cancer	0.00172	0.022	CbGeAlD
Hydroxyurea—CYP2D6—testis—prostate cancer	0.00111	0.0142	CbGeAlD
Hydroxyurea—Constipation—Mitoxantrone—prostate cancer	0.000199	0.00041	CcSEcCtD
Hydroxyurea—Pain—Mitoxantrone—prostate cancer	0.000199	0.00041	CcSEcCtD
Hydroxyurea—Angiopathy—Capecitabine—prostate cancer	0.000199	0.00041	CcSEcCtD
Hydroxyurea—Rash—Goserelin—prostate cancer	0.000199	0.000409	CcSEcCtD
Hydroxyurea—Dermatitis—Goserelin—prostate cancer	0.000199	0.000409	CcSEcCtD
Hydroxyurea—Vomiting—Conjugated Estrogens—prostate cancer	0.000199	0.000409	CcSEcCtD
Hydroxyurea—Body temperature increased—Estradiol—prostate cancer	0.000198	0.000407	CcSEcCtD
Hydroxyurea—Headache—Goserelin—prostate cancer	0.000198	0.000407	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—prostate cancer	0.000197	0.000406	CcSEcCtD
Hydroxyurea—Erythema—Docetaxel—prostate cancer	0.000197	0.000406	CcSEcCtD
Hydroxyurea—Rash—Conjugated Estrogens—prostate cancer	0.000197	0.000405	CcSEcCtD
Hydroxyurea—Chills—Capecitabine—prostate cancer	0.000197	0.000405	CcSEcCtD
Hydroxyurea—Dermatitis—Conjugated Estrogens—prostate cancer	0.000197	0.000405	CcSEcCtD
Hydroxyurea—Haemoglobin—Prednisone—prostate cancer	0.000196	0.000404	CcSEcCtD
Hydroxyurea—Headache—Conjugated Estrogens—prostate cancer	0.000196	0.000403	CcSEcCtD
Hydroxyurea—Haemorrhage—Prednisone—prostate cancer	0.000195	0.000402	CcSEcCtD
Hydroxyurea—Hallucination—Prednisone—prostate cancer	0.000194	0.0004	CcSEcCtD
Hydroxyurea—Alopecia—Capecitabine—prostate cancer	0.000194	0.000399	CcSEcCtD
Hydroxyurea—Infection—Etoposide—prostate cancer	0.000192	0.000396	CcSEcCtD
Hydroxyurea—Feeling abnormal—Mitoxantrone—prostate cancer	0.000192	0.000395	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—prostate cancer	0.000192	0.000394	CcSEcCtD
Hydroxyurea—Erythema—Capecitabine—prostate cancer	0.000191	0.000393	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Etoposide—prostate cancer	0.00019	0.00039	CcSEcCtD
Hydroxyurea—Skin disorder—Etoposide—prostate cancer	0.000188	0.000387	CcSEcCtD
Hydroxyurea—Nausea—Goserelin—prostate cancer	0.000187	0.000385	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—prostate cancer	0.000187	0.000385	CcSEcCtD
Hydroxyurea—Nausea—Conjugated Estrogens—prostate cancer	0.000186	0.000382	CcSEcCtD
Hydroxyurea—Breast disorder—Doxorubicin—prostate cancer	0.000185	0.00038	CcSEcCtD
Hydroxyurea—Anorexia—Etoposide—prostate cancer	0.000185	0.00038	CcSEcCtD
Hydroxyurea—Hypersensitivity—Estradiol—prostate cancer	0.000184	0.000379	CcSEcCtD
Hydroxyurea—Body temperature increased—Mitoxantrone—prostate cancer	0.000184	0.000379	CcSEcCtD
Hydroxyurea—Anaemia—Docetaxel—prostate cancer	0.000182	0.000375	CcSEcCtD
Hydroxyurea—Pancytopenia—Epirubicin—prostate cancer	0.000181	0.000373	CcSEcCtD
Hydroxyurea—Asthenia—Estradiol—prostate cancer	0.000179	0.000369	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—prostate cancer	0.000179	0.000368	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—prostate cancer	0.000179	0.000368	CcSEcCtD
Hydroxyurea—Angiopathy—Prednisone—prostate cancer	0.000177	0.000365	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Capecitabine—prostate cancer	0.000177	0.000365	CcSEcCtD
Hydroxyurea—Leukopenia—Docetaxel—prostate cancer	0.000177	0.000363	CcSEcCtD
Hydroxyurea—Anaemia—Capecitabine—prostate cancer	0.000177	0.000363	CcSEcCtD
Hydroxyurea—Weight increased—Epirubicin—prostate cancer	0.000174	0.000358	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—prostate cancer	0.000173	0.000357	CcSEcCtD
Hydroxyurea—Dyspnoea—Etoposide—prostate cancer	0.000173	0.000355	CcSEcCtD
Hydroxyurea—Alopecia—Prednisone—prostate cancer	0.000173	0.000355	CcSEcCtD
Hydroxyurea—Malaise—Capecitabine—prostate cancer	0.000172	0.000354	CcSEcCtD
Hydroxyurea—Somnolence—Etoposide—prostate cancer	0.000172	0.000354	CcSEcCtD
Hydroxyurea—Hypersensitivity—Mitoxantrone—prostate cancer	0.000172	0.000353	CcSEcCtD
Hydroxyurea—Diarrhoea—Estradiol—prostate cancer	0.000171	0.000352	CcSEcCtD
Hydroxyurea—Leukopenia—Capecitabine—prostate cancer	0.000171	0.000352	CcSEcCtD
Hydroxyurea—Convulsion—Docetaxel—prostate cancer	0.000171	0.000352	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—prostate cancer	0.00017	0.00035	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—prostate cancer	0.00017	0.00035	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—prostate cancer	0.00017	0.00035	CcSEcCtD
Hydroxyurea—Erythema—Prednisone—prostate cancer	0.00017	0.00035	CcSEcCtD
Hydroxyurea—Decreased appetite—Etoposide—prostate cancer	0.000168	0.000347	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—prostate cancer	0.000168	0.000345	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—prostate cancer	0.000167	0.000344	CcSEcCtD
Hydroxyurea—Asthenia—Mitoxantrone—prostate cancer	0.000167	0.000344	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—prostate cancer	0.000167	0.000344	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—prostate cancer	0.000167	0.000344	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000167	0.000343	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—prostate cancer	0.000166	0.000342	CcSEcCtD
Hydroxyurea—Pain—Etoposide—prostate cancer	0.000166	0.000341	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—prostate cancer	0.000166	0.000341	CcSEcCtD
Hydroxyurea—Dizziness—Estradiol—prostate cancer	0.000165	0.00034	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—prostate cancer	0.000165	0.00034	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—prostate cancer	0.000165	0.00034	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000161	0.000332	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Epirubicin—prostate cancer	0.000161	0.000331	CcSEcCtD
Hydroxyurea—Oedema—Docetaxel—prostate cancer	0.000161	0.000331	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—prostate cancer	0.000161	0.000331	CcSEcCtD
Hydroxyurea—Discomfort—Capecitabine—prostate cancer	0.000161	0.000331	CcSEcCtD
Hydroxyurea—Infection—Docetaxel—prostate cancer	0.00016	0.000329	CcSEcCtD
Hydroxyurea—Feeling abnormal—Etoposide—prostate cancer	0.00016	0.000329	CcSEcCtD
Hydroxyurea—Diarrhoea—Mitoxantrone—prostate cancer	0.000159	0.000328	CcSEcCtD
Hydroxyurea—Vomiting—Estradiol—prostate cancer	0.000159	0.000327	CcSEcCtD
Hydroxyurea—Nervous system disorder—Docetaxel—prostate cancer	0.000158	0.000325	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Prednisone—prostate cancer	0.000158	0.000325	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Docetaxel—prostate cancer	0.000158	0.000324	CcSEcCtD
Hydroxyurea—Rash—Estradiol—prostate cancer	0.000158	0.000324	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—prostate cancer	0.000158	0.000324	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—prostate cancer	0.000158	0.000324	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—prostate cancer	0.000158	0.000324	CcSEcCtD
Hydroxyurea—Dermatitis—Estradiol—prostate cancer	0.000157	0.000324	CcSEcCtD
Hydroxyurea—Anaemia—Prednisone—prostate cancer	0.000157	0.000324	CcSEcCtD
Hydroxyurea—Headache—Estradiol—prostate cancer	0.000157	0.000322	CcSEcCtD
Hydroxyurea—Skin disorder—Docetaxel—prostate cancer	0.000156	0.000322	CcSEcCtD
Hydroxyurea—Oedema—Capecitabine—prostate cancer	0.000156	0.000321	CcSEcCtD
Hydroxyurea—Infection—Capecitabine—prostate cancer	0.000155	0.000319	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000154	0.000318	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—prostate cancer	0.000154	0.000316	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—prostate cancer	0.000154	0.000316	CcSEcCtD
Hydroxyurea—Anorexia—Docetaxel—prostate cancer	0.000153	0.000316	CcSEcCtD
Hydroxyurea—Malaise—Prednisone—prostate cancer	0.000153	0.000316	CcSEcCtD
Hydroxyurea—Body temperature increased—Etoposide—prostate cancer	0.000153	0.000315	CcSEcCtD
Hydroxyurea—Nervous system disorder—Capecitabine—prostate cancer	0.000153	0.000315	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—prostate cancer	0.000153	0.000315	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Capecitabine—prostate cancer	0.000153	0.000314	CcSEcCtD
Hydroxyurea—Skin disorder—Capecitabine—prostate cancer	0.000151	0.000312	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000149	0.000307	CcSEcCtD
Hydroxyurea—Anorexia—Capecitabine—prostate cancer	0.000149	0.000306	CcSEcCtD
Hydroxyurea—Nausea—Estradiol—prostate cancer	0.000148	0.000306	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2C18—prostate cancer	0.000148	0.00067	CbGpPWpGaD
Hydroxyurea—Vomiting—Mitoxantrone—prostate cancer	0.000148	0.000305	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTA2—prostate cancer	0.000147	0.000666	CbGpPWpGaD
Hydroxyurea—Convulsion—Prednisone—prostate cancer	0.000147	0.000303	CcSEcCtD
Hydroxyurea—Rash—Mitoxantrone—prostate cancer	0.000147	0.000302	CcSEcCtD
Hydroxyurea—Dermatitis—Mitoxantrone—prostate cancer	0.000147	0.000302	CcSEcCtD
Hydroxyurea—Headache—Mitoxantrone—prostate cancer	0.000146	0.0003	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ABCG5—prostate cancer	0.000146	0.000658	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SULT1A1—prostate cancer	0.000146	0.000658	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000144	0.000296	CcSEcCtD
Hydroxyurea—Dyspnoea—Docetaxel—prostate cancer	0.000144	0.000295	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NCOA3—prostate cancer	0.000143	0.000647	CbGpPWpGaD
Hydroxyurea—Somnolence—Docetaxel—prostate cancer	0.000143	0.000295	CcSEcCtD
Hydroxyurea—Discomfort—Prednisone—prostate cancer	0.000143	0.000295	CcSEcCtD
Hydroxyurea—Hypersensitivity—Etoposide—prostate cancer	0.000143	0.000294	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TERT—prostate cancer	0.000143	0.000644	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA1—prostate cancer	0.000142	0.000643	CbGpPWpGaD
Hydroxyurea—Haemoglobin—Doxorubicin—prostate cancer	0.000142	0.000293	CcSEcCtD
Hydroxyurea—Dyspepsia—Docetaxel—prostate cancer	0.000142	0.000292	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—prostate cancer	0.000141	0.000291	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTO1—prostate cancer	0.000141	0.000636	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HSD3B2—prostate cancer	0.000141	0.000636	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NAT2—prostate cancer	0.000141	0.000636	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Docetaxel—prostate cancer	0.00014	0.000288	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—SULT2A1—prostate cancer	0.00014	0.000631	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000139	0.000286	CcSEcCtD
Hydroxyurea—Asthenia—Etoposide—prostate cancer	0.000139	0.000286	CcSEcCtD
Hydroxyurea—Dyspnoea—Capecitabine—prostate cancer	0.000139	0.000286	CcSEcCtD
Hydroxyurea—Oedema—Prednisone—prostate cancer	0.000139	0.000286	CcSEcCtD
Hydroxyurea—Fatigue—Docetaxel—prostate cancer	0.000139	0.000286	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—prostate cancer	0.000139	0.000285	CcSEcCtD
Hydroxyurea—Nausea—Mitoxantrone—prostate cancer	0.000138	0.000285	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	0.000138	0.000624	CbGpPWpGaD
Hydroxyurea—Infection—Prednisone—prostate cancer	0.000138	0.000284	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—SULT2A1—prostate cancer	0.000138	0.000622	CbGpPWpGaD
Hydroxyurea—Constipation—Docetaxel—prostate cancer	0.000138	0.000283	CcSEcCtD
Hydroxyurea—Pain—Docetaxel—prostate cancer	0.000138	0.000283	CcSEcCtD
Hydroxyurea—Dyspepsia—Capecitabine—prostate cancer	0.000137	0.000282	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—prostate cancer	0.000137	0.000282	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—HPGDS—prostate cancer	0.000137	0.000617	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Prednisone—prostate cancer	0.000136	0.00028	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP2C19—prostate cancer	0.000136	0.000613	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Capecitabine—prostate cancer	0.000136	0.000279	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—prostate cancer	0.000135	0.000278	CcSEcCtD
Hydroxyurea—Skin disorder—Prednisone—prostate cancer	0.000135	0.000278	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—LRP2—prostate cancer	0.000135	0.000609	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PLCB2—prostate cancer	0.000135	0.000609	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2C18—prostate cancer	0.000135	0.000609	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000135	0.000277	CcSEcCtD
Hydroxyurea—Fatigue—Capecitabine—prostate cancer	0.000134	0.000277	CcSEcCtD
Hydroxyurea—Pain—Capecitabine—prostate cancer	0.000133	0.000274	CcSEcCtD
Hydroxyurea—Constipation—Capecitabine—prostate cancer	0.000133	0.000274	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—prostate cancer	0.000133	0.000274	CcSEcCtD
Hydroxyurea—Feeling abnormal—Docetaxel—prostate cancer	0.000133	0.000273	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—prostate cancer	0.000133	0.000273	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ACHE—prostate cancer	0.000132	0.000598	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTT1—prostate cancer	0.000132	0.000598	CbGpPWpGaD
Hydroxyurea—Anorexia—Prednisone—prostate cancer	0.000132	0.000272	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—P4HB—prostate cancer	0.000132	0.000598	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GPX3—prostate cancer	0.000131	0.000594	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2A6—prostate cancer	0.000131	0.000592	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC22A1—prostate cancer	0.000129	0.000581	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	0.000129	0.000581	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Capecitabine—prostate cancer	0.000128	0.000264	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—prostate cancer	0.000128	0.000264	CcSEcCtD
Hydroxyurea—Dizziness—Etoposide—prostate cancer	0.000128	0.000264	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—ATM—prostate cancer	0.000128	0.000579	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKR1C3—prostate cancer	0.000127	0.000575	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Docetaxel—prostate cancer	0.000127	0.000262	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—prostate cancer	0.000127	0.000261	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PRKACB—prostate cancer	0.000127	0.000572	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP17A1—prostate cancer	0.000125	0.000566	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SULT2A1—prostate cancer	0.000125	0.000566	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—HPGDS—prostate cancer	0.000125	0.000566	CbGpPWpGaD
Hydroxyurea—Alopecia—Doxorubicin—prostate cancer	0.000125	0.000257	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2C19—prostate cancer	0.000125	0.000563	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Epirubicin—prostate cancer	0.000123	0.000254	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—MED12—prostate cancer	0.000123	0.000557	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Capecitabine—prostate cancer	0.000123	0.000254	CcSEcCtD
Hydroxyurea—Vomiting—Etoposide—prostate cancer	0.000123	0.000254	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—prostate cancer	0.000123	0.000253	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—prostate cancer	0.000123	0.000253	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2C19—prostate cancer	0.000123	0.000555	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GNG5—prostate cancer	0.000122	0.000553	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Prednisone—prostate cancer	0.000122	0.000252	CcSEcCtD
Hydroxyurea—Rash—Etoposide—prostate cancer	0.000122	0.000251	CcSEcCtD
Hydroxyurea—Dermatitis—Etoposide—prostate cancer	0.000122	0.000251	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—prostate cancer	0.000122	0.000549	CbGpPWpGaD
Hydroxyurea—Headache—Etoposide—prostate cancer	0.000121	0.00025	CcSEcCtD
Hydroxyurea—Decreased appetite—Prednisone—prostate cancer	0.000121	0.000248	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2A6—prostate cancer	0.00012	0.000543	CbGpPWpGaD
Hydroxyurea—Malaise—Epirubicin—prostate cancer	0.00012	0.000247	CcSEcCtD
Hydroxyurea—Fatigue—Prednisone—prostate cancer	0.00012	0.000246	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NCOA2—prostate cancer	0.000119	0.00054	CbGpPWpGaD
Hydroxyurea—Leukopenia—Epirubicin—prostate cancer	0.000119	0.000245	CcSEcCtD
Hydroxyurea—Constipation—Prednisone—prostate cancer	0.000119	0.000244	CcSEcCtD
Hydroxyurea—Hypersensitivity—Docetaxel—prostate cancer	0.000119	0.000244	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NCOA3—prostate cancer	0.000118	0.000533	CbGpPWpGaD
Hydroxyurea—Asthenia—Docetaxel—prostate cancer	0.000116	0.000238	CcSEcCtD
Hydroxyurea—Convulsion—Epirubicin—prostate cancer	0.000115	0.000237	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—AKR1C3—prostate cancer	0.000115	0.000521	CbGpPWpGaD
Hydroxyurea—Nausea—Etoposide—prostate cancer	0.000115	0.000237	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP17A1—prostate cancer	0.000115	0.00052	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Capecitabine—prostate cancer	0.000115	0.000236	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisone—prostate cancer	0.000114	0.000235	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—prostate cancer	0.000114	0.000235	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—SLC5A5—prostate cancer	0.000114	0.000515	CbGpPWpGaD
Hydroxyurea—Anaemia—Doxorubicin—prostate cancer	0.000114	0.000234	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP17A1—prostate cancer	0.000113	0.000513	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000113	0.000232	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—HPGDS—prostate cancer	0.000112	0.000508	CbGpPWpGaD
Hydroxyurea—Discomfort—Epirubicin—prostate cancer	0.000112	0.00023	CcSEcCtD
Hydroxyurea—Asthenia—Capecitabine—prostate cancer	0.000112	0.00023	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP2C19—prostate cancer	0.000112	0.000505	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2E1—prostate cancer	0.000111	0.000503	CbGpPWpGaD
Hydroxyurea—Malaise—Doxorubicin—prostate cancer	0.000111	0.000229	CcSEcCtD
Hydroxyurea—Leukopenia—Doxorubicin—prostate cancer	0.00011	0.000227	CcSEcCtD
Hydroxyurea—Diarrhoea—Docetaxel—prostate cancer	0.00011	0.000227	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NQO1—prostate cancer	0.00011	0.000497	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Prednisone—prostate cancer	0.00011	0.000226	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—NCOA2—prostate cancer	0.00011	0.000495	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTT1—prostate cancer	0.000109	0.000493	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ACHE—prostate cancer	0.000109	0.000493	CbGpPWpGaD
Hydroxyurea—Oedema—Epirubicin—prostate cancer	0.000109	0.000224	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TH—prostate cancer	0.000108	0.00049	CbGpPWpGaD
Hydroxyurea—Infection—Epirubicin—prostate cancer	0.000108	0.000222	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP2A6—prostate cancer	0.000108	0.000487	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP3A4—prostate cancer	0.000107	0.000485	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—prostate cancer	0.000107	0.00022	CcSEcCtD
Hydroxyurea—Diarrhoea—Capecitabine—prostate cancer	0.000107	0.00022	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—prostate cancer	0.000107	0.000219	CcSEcCtD
Hydroxyurea—Dizziness—Docetaxel—prostate cancer	0.000106	0.000219	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—prostate cancer	0.000106	0.000219	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP1B1—prostate cancer	0.000106	0.000477	CbGpPWpGaD
Hydroxyurea—Skin disorder—Epirubicin—prostate cancer	0.000105	0.000217	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—AKR1C3—prostate cancer	0.000105	0.000474	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PRKACB—prostate cancer	0.000104	0.000471	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000104	0.000214	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—prostate cancer	0.000104	0.000213	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—prostate cancer	0.000104	0.000213	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP17A1—prostate cancer	0.000103	0.000466	CbGpPWpGaD
Hydroxyurea—Dizziness—Capecitabine—prostate cancer	0.000103	0.000212	CcSEcCtD
Hydroxyurea—Vomiting—Docetaxel—prostate cancer	0.000102	0.000211	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisone—prostate cancer	0.000102	0.000211	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GGT1—prostate cancer	0.000102	0.000462	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2E1—prostate cancer	0.000102	0.000461	CbGpPWpGaD
Hydroxyurea—Rash—Docetaxel—prostate cancer	0.000102	0.000209	CcSEcCtD
Hydroxyurea—Dermatitis—Docetaxel—prostate cancer	0.000101	0.000209	CcSEcCtD
Hydroxyurea—Headache—Docetaxel—prostate cancer	0.000101	0.000208	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2E1—prostate cancer	0.000101	0.000455	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOA1—prostate cancer	0.000101	0.000455	CbGpPWpGaD
Hydroxyurea—Oedema—Doxorubicin—prostate cancer	0.0001	0.000207	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—prostate cancer	9.98e-05	0.000205	CcSEcCtD
Hydroxyurea—Asthenia—Prednisone—prostate cancer	9.96e-05	0.000205	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP19A1—prostate cancer	9.92e-05	0.000448	CbGpPWpGaD
Hydroxyurea—Vomiting—Capecitabine—prostate cancer	9.91e-05	0.000204	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—prostate cancer	9.85e-05	0.000203	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP3A4—prostate cancer	9.85e-05	0.000445	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOA2—prostate cancer	9.84e-05	0.000445	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Doxorubicin—prostate cancer	9.84e-05	0.000202	CcSEcCtD
Hydroxyurea—Rash—Capecitabine—prostate cancer	9.83e-05	0.000202	CcSEcCtD
Hydroxyurea—Dermatitis—Capecitabine—prostate cancer	9.82e-05	0.000202	CcSEcCtD
Hydroxyurea—Headache—Capecitabine—prostate cancer	9.77e-05	0.000201	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—prostate cancer	9.76e-05	0.000201	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP3A4—prostate cancer	9.71e-05	0.000439	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1B1—prostate cancer	9.68e-05	0.000437	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Epirubicin—prostate cancer	9.68e-05	0.000199	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1B—prostate cancer	9.66e-05	0.000436	CbGpPWpGaD
Hydroxyurea—Somnolence—Epirubicin—prostate cancer	9.65e-05	0.000199	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—prostate cancer	9.58e-05	0.000197	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—RXRA—prostate cancer	9.58e-05	0.000433	CbGpPWpGaD
Hydroxyurea—Nausea—Docetaxel—prostate cancer	9.56e-05	0.000197	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—prostate cancer	9.56e-05	0.000197	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1B1—prostate cancer	9.55e-05	0.000431	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Prednisone—prostate cancer	9.5e-05	0.000196	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MDM2—prostate cancer	9.46e-05	0.000427	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Epirubicin—prostate cancer	9.44e-05	0.000194	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SLC5A5—prostate cancer	9.39e-05	0.000424	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GGT1—prostate cancer	9.38e-05	0.000424	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—prostate cancer	9.38e-05	0.000193	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—prostate cancer	9.36e-05	0.000193	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—prostate cancer	9.29e-05	0.000191	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—prostate cancer	9.29e-05	0.000191	CcSEcCtD
Hydroxyurea—Nausea—Capecitabine—prostate cancer	9.26e-05	0.000191	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—NCOA1—prostate cancer	9.24e-05	0.000417	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—COMT—prostate cancer	9.22e-05	0.000417	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—prostate cancer	9.21e-05	0.000416	CbGpPWpGaD
Hydroxyurea—Dizziness—Prednisone—prostate cancer	9.18e-05	0.000189	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GSTP1—prostate cancer	9.18e-05	0.000415	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2E1—prostate cancer	9.17e-05	0.000414	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP19A1—prostate cancer	9.1e-05	0.000411	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NQO1—prostate cancer	9.07e-05	0.00041	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ITPR1—prostate cancer	9.03e-05	0.000408	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP19A1—prostate cancer	8.98e-05	0.000406	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—prostate cancer	8.96e-05	0.000184	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—prostate cancer	8.95e-05	0.000184	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TH—prostate cancer	8.93e-05	0.000404	CbGpPWpGaD
Hydroxyurea—Somnolence—Doxorubicin—prostate cancer	8.93e-05	0.000184	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—prostate cancer	8.91e-05	0.000403	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Doxorubicin—prostate cancer	8.85e-05	0.000182	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP3A4—prostate cancer	8.84e-05	0.000399	CbGpPWpGaD
Hydroxyurea—Vomiting—Prednisone—prostate cancer	8.83e-05	0.000182	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—RXRA—prostate cancer	8.79e-05	0.000397	CbGpPWpGaD
Hydroxyurea—Rash—Prednisone—prostate cancer	8.76e-05	0.00018	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisone—prostate cancer	8.75e-05	0.00018	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—prostate cancer	8.74e-05	0.00018	CcSEcCtD
Hydroxyurea—Headache—Prednisone—prostate cancer	8.7e-05	0.000179	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP1B1—prostate cancer	8.69e-05	0.000393	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.68e-05	0.000179	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—prostate cancer	8.66e-05	0.000178	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN1B—prostate cancer	8.64e-05	0.00039	CbGpPWpGaD
Hydroxyurea—Pain—Doxorubicin—prostate cancer	8.59e-05	0.000177	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—prostate cancer	8.59e-05	0.000177	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—prostate cancer	8.59e-05	0.000177	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TYMS—prostate cancer	8.54e-05	0.000386	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—EP300—prostate cancer	8.48e-05	0.000383	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—COMT—prostate cancer	8.46e-05	0.000382	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTM1—prostate cancer	8.44e-05	0.000381	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—prostate cancer	8.42e-05	0.000381	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GGT1—prostate cancer	8.42e-05	0.00038	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—COMT—prostate cancer	8.35e-05	0.000377	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—prostate cancer	8.31e-05	0.000375	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOA1—prostate cancer	8.29e-05	0.000375	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—LPL—prostate cancer	8.28e-05	0.000374	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Doxorubicin—prostate cancer	8.28e-05	0.00017	CcSEcCtD
Hydroxyurea—Nausea—Prednisone—prostate cancer	8.25e-05	0.00017	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CCND1—prostate cancer	8.24e-05	0.000372	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP19A1—prostate cancer	8.17e-05	0.000369	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Epirubicin—prostate cancer	8e-05	0.000165	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP1A1—prostate cancer	8e-05	0.000361	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—prostate cancer	7.97e-05	0.00036	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Doxorubicin—prostate cancer	7.94e-05	0.000163	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ERCC2—prostate cancer	7.93e-05	0.000358	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—RXRA—prostate cancer	7.89e-05	0.000356	CbGpPWpGaD
Hydroxyurea—Asthenia—Epirubicin—prostate cancer	7.79e-05	0.00016	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM1—prostate cancer	7.74e-05	0.00035	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM1—prostate cancer	7.63e-05	0.000345	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—COMT—prostate cancer	7.6e-05	0.000343	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—EP300—prostate cancer	7.58e-05	0.000343	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTP1—prostate cancer	7.56e-05	0.000342	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTHFR—prostate cancer	7.46e-05	0.000337	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ITPR1—prostate cancer	7.44e-05	0.000336	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Epirubicin—prostate cancer	7.43e-05	0.000153	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—prostate cancer	7.4e-05	0.000152	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—prostate cancer	7.39e-05	0.000334	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1A1—prostate cancer	7.34e-05	0.000332	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPARA—prostate cancer	7.32e-05	0.000331	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HAO1—prostate cancer	7.24e-05	0.000327	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1A1—prostate cancer	7.24e-05	0.000327	CbGpPWpGaD
Hydroxyurea—Asthenia—Doxorubicin—prostate cancer	7.21e-05	0.000148	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—prostate cancer	7.18e-05	0.000148	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMS—prostate cancer	7.03e-05	0.000318	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTM1—prostate cancer	6.95e-05	0.000314	CbGpPWpGaD
Hydroxyurea—Vomiting—Epirubicin—prostate cancer	6.9e-05	0.000142	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CAV1—prostate cancer	6.88e-05	0.000311	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Doxorubicin—prostate cancer	6.88e-05	0.000141	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—prostate cancer	6.85e-05	0.000141	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—prostate cancer	6.84e-05	0.000141	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—LPL—prostate cancer	6.82e-05	0.000308	CbGpPWpGaD
Hydroxyurea—Headache—Epirubicin—prostate cancer	6.8e-05	0.00014	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—prostate cancer	6.64e-05	0.000137	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MYC—prostate cancer	6.61e-05	0.000299	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP1A1—prostate cancer	6.59e-05	0.000298	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ERCC2—prostate cancer	6.53e-05	0.000295	CbGpPWpGaD
Hydroxyurea—Nausea—Epirubicin—prostate cancer	6.45e-05	0.000133	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—prostate cancer	6.39e-05	0.000131	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—prostate cancer	6.34e-05	0.00013	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—prostate cancer	6.33e-05	0.00013	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—prostate cancer	6.3e-05	0.00013	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CG—prostate cancer	6.26e-05	0.000283	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTHFR—prostate cancer	6.14e-05	0.000277	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPARA—prostate cancer	6.02e-05	0.000272	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—prostate cancer	5.97e-05	0.000123	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—INS—prostate cancer	5.93e-05	0.000268	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TST—prostate cancer	5.9e-05	0.000267	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CSAD—prostate cancer	5.9e-05	0.000267	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GRHL1—prostate cancer	5.9e-05	0.000267	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ADI1—prostate cancer	5.9e-05	0.000267	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CBR1—prostate cancer	5.9e-05	0.000267	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PSAT1—prostate cancer	5.9e-05	0.000267	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CREBBP—prostate cancer	5.81e-05	0.000262	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CAV1—prostate cancer	5.66e-05	0.000256	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CD—prostate cancer	5.51e-05	0.000249	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GRHPR—prostate cancer	5.49e-05	0.000248	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—UGT2B17—prostate cancer	5.49e-05	0.000248	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—UGT2B15—prostate cancer	5.49e-05	0.000248	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CKMT2—prostate cancer	5.49e-05	0.000248	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—prostate cancer	5.43e-05	0.000245	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NOS3—prostate cancer	5.2e-05	0.000235	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SULT2B1—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PGAM2—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MBTPS1—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RFK—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM3—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AOX1—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAGLU—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CG—prostate cancer	5.16e-05	0.000233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AMACR—prostate cancer	4.89e-05	0.000221	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP3A43—prostate cancer	4.89e-05	0.000221	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SRD5A2—prostate cancer	4.89e-05	0.000221	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—DEGS1—prostate cancer	4.89e-05	0.000221	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAT1—prostate cancer	4.89e-05	0.000221	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—INS—prostate cancer	4.88e-05	0.000221	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CB—prostate cancer	4.8e-05	0.000217	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CREBBP—prostate cancer	4.78e-05	0.000216	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—prostate cancer	4.76e-05	0.000215	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSD17B1—prostate cancer	4.67e-05	0.000211	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CD—prostate cancer	4.54e-05	0.000205	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NOS3—prostate cancer	4.28e-05	0.000193	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HPGD—prostate cancer	4.16e-05	0.000188	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—B4GALT4—prostate cancer	4.16e-05	0.000188	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—prostate cancer	4.15e-05	0.000187	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—EP300—prostate cancer	3.96e-05	0.000179	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CB—prostate cancer	3.95e-05	0.000179	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—prostate cancer	3.92e-05	0.000177	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TNFRSF21—prostate cancer	3.91e-05	0.000177	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTAP—prostate cancer	3.8e-05	0.000172	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP7B1—prostate cancer	3.8e-05	0.000172	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SULT1E1—prostate cancer	3.71e-05	0.000167	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SRD5A1—prostate cancer	3.71e-05	0.000167	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ACSL4—prostate cancer	3.54e-05	0.00016	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSD17B3—prostate cancer	3.54e-05	0.00016	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—prostate cancer	3.42e-05	0.000154	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—UMPS—prostate cancer	3.39e-05	0.000153	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PHGDH—prostate cancer	3.39e-05	0.000153	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ARG2—prostate cancer	3.39e-05	0.000153	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—LDHB—prostate cancer	3.33e-05	0.00015	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP3A5—prostate cancer	3.26e-05	0.000147	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—EP300—prostate cancer	3.26e-05	0.000147	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—UCP3—prostate cancer	3.15e-05	0.000142	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PDHA1—prostate cancer	3.15e-05	0.000142	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA3—prostate cancer	3.15e-05	0.000142	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TCN2—prostate cancer	3.15e-05	0.000142	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSD3B1—prostate cancer	3.01e-05	0.000136	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC22A3—prostate cancer	3.01e-05	0.000136	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—prostate cancer	2.93e-05	0.000132	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TBXAS1—prostate cancer	2.88e-05	0.00013	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA4—prostate cancer	2.88e-05	0.00013	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA2—prostate cancer	2.81e-05	0.000127	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SULT1A1—prostate cancer	2.78e-05	0.000125	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCG5—prostate cancer	2.78e-05	0.000125	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA1—prostate cancer	2.71e-05	0.000122	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAT2—prostate cancer	2.68e-05	0.000121	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSD3B2—prostate cancer	2.68e-05	0.000121	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTO1—prostate cancer	2.68e-05	0.000121	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PLCB2—prostate cancer	2.57e-05	0.000116	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2C18—prostate cancer	2.57e-05	0.000116	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—LRP2—prostate cancer	2.57e-05	0.000116	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—P4HB—prostate cancer	2.52e-05	0.000114	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC22A1—prostate cancer	2.45e-05	0.000111	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—prostate cancer	2.41e-05	0.000109	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—prostate cancer	2.39e-05	0.000108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SULT2A1—prostate cancer	2.39e-05	0.000108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MED12—prostate cancer	2.35e-05	0.000106	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GNG5—prostate cancer	2.33e-05	0.000105	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA3—prostate cancer	2.25e-05	0.000101	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HPGDS—prostate cancer	2.14e-05	9.68e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2C19—prostate cancer	2.13e-05	9.62e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ACHE—prostate cancer	2.08e-05	9.39e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—prostate cancer	2.08e-05	9.39e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2A6—prostate cancer	2.05e-05	9.28e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKR1C3—prostate cancer	2e-05	9.03e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PRKACB—prostate cancer	1.99e-05	8.98e-05	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—prostate cancer	1.97e-05	8.89e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.97e-05	8.89e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA2—prostate cancer	1.87e-05	8.47e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.79e-05	8.08e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.75e-05	7.89e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NQO1—prostate cancer	1.73e-05	7.8e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TH—prostate cancer	1.7e-05	7.69e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.68e-05	7.61e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.66e-05	7.48e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GGT1—prostate cancer	1.6e-05	7.25e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA1—prostate cancer	1.58e-05	7.14e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.56e-05	7.03e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RXRA—prostate cancer	1.5e-05	6.79e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—COMT—prostate cancer	1.45e-05	6.54e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—prostate cancer	1.44e-05	6.51e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ITPR1—prostate cancer	1.42e-05	6.4e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMS—prostate cancer	1.34e-05	6.05e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM1—prostate cancer	1.32e-05	5.98e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—LPL—prostate cancer	1.3e-05	5.87e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.25e-05	5.67e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ERCC2—prostate cancer	1.24e-05	5.62e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—prostate cancer	1.17e-05	5.29e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARA—prostate cancer	1.15e-05	5.19e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CAV1—prostate cancer	1.08e-05	4.88e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—prostate cancer	9.83e-06	4.44e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—INS—prostate cancer	9.3e-06	4.2e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CREBBP—prostate cancer	9.11e-06	4.12e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CD—prostate cancer	8.64e-06	3.9e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NOS3—prostate cancer	8.16e-06	3.69e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CB—prostate cancer	7.53e-06	3.4e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—prostate cancer	7.46e-06	3.37e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—prostate cancer	6.51e-06	2.94e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—EP300—prostate cancer	6.21e-06	2.8e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.59e-06	2.07e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—prostate cancer	3.75e-06	1.69e-05	CbGpPWpGaD
